Financial Statements — BSEM
Balance Sheet
(in millions USD)| Metric | Q2
2026 |
|---|
| Cash & Equivalents | 6.96 |
| Accounts Receivable | 6.62 |
| Inventory | 4.71 |
| Total Current Assets | 20.78 |
| Property, Plant & Equipment | 4.42 |
| Goodwill | 1.53 |
| Intangible Assets | 21.36 |
| Total Non-current Assets* | 28.04 |
| Total Assets | 48.82 |
| Accounts Payable | 9.46 |
| Total Current Liabilities | 21.20 |
| Long-term Debt | 0.00 |
| Total Non-current Liabilities | 0.00 |
| Total Liabilities | 21.20 |
| Retained Earnings | (38.97) |
| Total Stockholder Equity | 27.61 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 |
|---|
| Total Revenue | 7.90 |
| Cost of Revenue | 3.06 |
| Gross Profit | 4.84 |
| Research & Development | 0.73 |
| Selling, General & Admin | 6.50 |
| Total Operating Expenses | 13.24 |
| Operating Income | (8.40) |
| Pretax Income | (8.97) |
| Tax Provision | 0.00 |
| Net Income | (8.97) |
| Basic EPS | (0.52) |
| Diluted EPS | (0.52) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 |
|---|
| Operating Cash Flow | (6.36) |
| Capital Expenditures | 0.06 |
| Free Cash Flow* | (6.42) |
| Investing Cash Flow | (15.08) |
| Financing Cash Flow | (1.15) |
* Derived from reported values
